335 related articles for article (PubMed ID: 26543389)
1. Emerging drugs of abuse: current perspectives on synthetic cannabinoids.
Debruyne D; Le Boisselier R
Subst Abuse Rehabil; 2015; 6():113-29. PubMed ID: 26543389
[TBL] [Abstract][Full Text] [Related]
2. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs of abuse: current perspectives on substituted cathinones.
Paillet-Loilier M; Cesbron A; Le Boisselier R; Bourgine J; Debruyne D
Subst Abuse Rehabil; 2014; 5():37-52. PubMed ID: 24966713
[TBL] [Abstract][Full Text] [Related]
4. Beyond THC: The New Generation of Cannabinoid Designer Drugs.
Fattore L; Fratta W
Front Behav Neurosci; 2011; 5():60. PubMed ID: 22007163
[TBL] [Abstract][Full Text] [Related]
5. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
Cottencin O; Rolland B; Karila L
Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
[TBL] [Abstract][Full Text] [Related]
6. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
Gudsoorkar VS; Perez JA
Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
[TBL] [Abstract][Full Text] [Related]
7. [Spice drugs: cannabinoids as a new designer drugs].
Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
[TBL] [Abstract][Full Text] [Related]
8. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
Seely KA; Lapoint J; Moran JH; Fattore L
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):234-43. PubMed ID: 22561602
[TBL] [Abstract][Full Text] [Related]
9. The Synthetic Cannabinoids Phenomenon.
Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health.
Bukke VN; Archana M; Villani R; Serviddio G; Cassano T
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681189
[TBL] [Abstract][Full Text] [Related]
11. Spice/K2 drugs--more than innocent substitutes for marijuana.
Zawilska JB; Wojcieszak J
Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity associated to synthetic cannabinoids use.
Solimini R; Busardò FP; Rotolo MC; Ricci S; Mastrobattista L; Mortali C; Graziano S; Pellegrini M; di Luca NM; Palmi I
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):1-6. PubMed ID: 28379600
[TBL] [Abstract][Full Text] [Related]
13. A survey study to characterize use of Spice products (synthetic cannabinoids).
Vandrey R; Dunn KE; Fry JA; Girling ER
Drug Alcohol Depend; 2012 Jan; 120(1-3):238-41. PubMed ID: 21835562
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
15. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Cannabinoids.
Mills B; Yepes A; Nugent K
Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
[TBL] [Abstract][Full Text] [Related]
17. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
Zawilska JB
Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
19. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
Brents LK; Prather PL
Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277
[TBL] [Abstract][Full Text] [Related]
20. Advances in urinary biomarker research of synthetic cannabinoids.
Wang Z; Leow EYQ; Moy HY; Chan ECY
Adv Clin Chem; 2023; 115():1-32. PubMed ID: 37673518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
